Comments (9)

Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of ‘real-world’ vaccination outcomes from Israel

Paul R Hunter, Julii Brainard
doi: https://doi.org/10.1101/2021.02.01.21250957
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article usage

Article usage: February 2021 to February 2022

Show by monthAbstractFull-text HTMLPDF
Total                  120,1556,80718,356
Picked up by 19 news outlets
Blogged by 6
Tweeted by 1193
On 1 Facebook pages
On 1 videos
Blog posts linking to this article:
Tweets referencing this article:
Back to top
Posted February 03, 2021.
Download PDF
Data/Code
Email
Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of ‘real-world’ vaccination outcomes from Israel
Paul R Hunter, Julii Brainard
medRxiv 2021.02.01.21250957; doi: https://doi.org/10.1101/2021.02.01.21250957
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools

Subject Area

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.